+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

COVID-19: HC asks BMC to furnish details about PPE kits

May 12, 2020, 18:47 IST
PTI
Mumbai, May 12 () The Bombay High Court on Tuesdaydirected the Brihanmumbai Municipal Corporation to respond toa PIL seeking PPE kits for frontline health workers andlimiting the use of hydroxychloroquine for COVID-19 treatment.

A bench of Chief Justice Dipankar Datta and JusticeA A Sayyed directed the BMC to file an affidavit by Wednesday,detailing the number of PPE kits it had already provided,apart from other health and security measures taken to protectdoctors, health workers, civic employees etc.

Advertisement

The court also directed the civic body to respond toall other contentions raised in the PIL, including theaccessibility of screening tests for frontline workers and forthe poor.

The PIL by Jan Swasthya Abhiyan also claimed thatthere weren't enough healthcare professionals and frontlineworkers in hospitals and facilities at some quarantine centreswere inadequate.

The petitioner's counsel Mihir Desai said doctors andmedical staff who were not treating COVID-19 patients alsoneeded PPE kits.

Meanwhile, the BMC's counsel senior advocate AnilSakhre argued that the state was providing as many PPEs aspossible and each kit costs Rs 2,200 per day for each personper shift.

Advertisement

"We are trying to increase the production of PPEs,but until then, it is not feasible to provide PPEs to doctorsor staff who were not treating coronavirus patients," Sakhresaid.

The petitioner has also urged the authorities not touse hydroxychloroquine indiscrimnately, as there was notenough clinical evidence to show it effectively treats theinfection, he said.

The court will take up the matter for further hearingon May 15. AYAARU ARU

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
Next Article